CD40 and cholangiocarcinoma: In vitro experiments have demonstrated that specific blockade of tumor-secreted IL-10 and TGF-β can lead to the up-regulation of CD40, thereby enhancing the cytolytic activity of effector T cells against CCA cells (178).